Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Deferred Taxes (2016 - 2018)

Historic Deferred Taxes for Apyx Medical (APYX) over the last 7 years, with Q4 2018 value amounting to $736000.0.

  • Apyx Medical's Deferred Taxes rose 27551.02% to $736000.0 in Q4 2018 from the same period last year, while for Dec 2019 it was $932000.0, marking a year-over-year increase of 566.89%. This contributed to the annual value of $368000.0 for FY2018, which is 8775.51% up from last year.
  • According to the latest figures from Q4 2018, Apyx Medical's Deferred Taxes is $736000.0, which was up 27551.02% from $196000.0 recorded in Q4 2017.
  • Apyx Medical's 5-year Deferred Taxes high stood at $5.9 million for Q4 2014, and its period low was -$1.3 million during Q3 2014.
  • For the 4-year period, Apyx Medical's Deferred Taxes averaged around $605375.0, with its median value being $10000.0 (2014).
  • Over the last 5 years, Apyx Medical's Deferred Taxes had its largest YoY gain of 119200.74% in 2014, and its largest YoY loss of 10974.21% in 2014.
  • Over the past 4 years, Apyx Medical's Deferred Taxes (Quarter) stood at $5.9 million in 2014, then tumbled by 100.85% to -$50000.0 in 2016, then soared by 492.0% to $196000.0 in 2017, then surged by 275.51% to $736000.0 in 2018.
  • Its Deferred Taxes was $736000.0 in Q4 2018, compared to $196000.0 in Q4 2017 and -$50000.0 in Q4 2016.